CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Cannabis and cannabinoids in France
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Daily regulatory updates of legal changes in the cannabis sector, including monthly compilations
15th May 2023
France: Health minister François Braun has said that hexahydrocannabinol (HHC) will be banned in the coming weeks. "It is not classified as narcotic and I honestly think it will be soon," concluded the minister, implying that an opinion of the National Agency for the Safety of Medicines and Health Products (ANSM) will soon be issued.28th April 2023
- France: Deputy Victor Habert-Dassault, from the Republicans, presented a parliamentary question to the minister of health asking whether the government is considering banning hexahydrocannabinol (HHC)-containing products.
4th April 2023
France: The National Drug Safety Agency (ANSM) is warning of a possible shortage of CBD-only medicines in its medical cannabis pilot programme and suggests alternatives, such as Epidyolex and preparations that contain THC, for patients already in the programme. The anticipated shortage follows the withdrawal from the programme of Little Green Pharma, which provides approximately 60% of the products prescribed, press reports.
3rd February 2023
- France: The National Drug Safety Agency (ANSM) has updated the list of community pharmacies and healthcare establishments authorised to order and dispense medical cannabis.
25th January 2023
- France: The Economic, Social and Environmental Council (CESE) – a government and Parliament advisory body – adopted an opinion in favour of recreational cannabis legalisation. The CESE believes that from the point of view of public health, the preventive actions carried out are globally ineffective, in particular among young consumers who are increasingly exposed to uncontrolled products. The Council proposes a complete overhaul of the current regulatory framework in order to establish a desirable model for the controlled legalisation of recreational cannabis usage, production and distribution.
9th January 2023
- France: The highest administrative court in France, the Council of State, published the judgement that annulled Article 1.II of the Decree of 30th December 2021 banning the sale, possession and consumption of hemp flowers. The Council of State concluded that CBD does not have psychotropic effects and does not create a public health risk that would justify such a general and absolute prohibition.
16th December 2022
- France: The highest administrative court in France, the Council of State, ruled on the legitimacy of Article 1.II of the Decree of 30th December 2021 banning the sale, possession and consumption of hemp flowers. It concluded that the ban should be annulled because of a manifestly disproportionate interference with the free movement of goods, as CBD is not a narcotic. The judgement is expected to be published by the end of the year.
14th December 2022
France: The highest administrative court in France, the Council of State, was due to rule today on the legitimacy of the Decree of 30th December 2021 banning the sale, possession and consumption of hemp flowers, media reports. The ban was temporarily suspended by the Council of State in January 2022 following an appeal by several industry members.
22nd November 2022
French Polynesia: With 33 votes and 20 abstentions, the Assembly has approved a law legalising the medical and industrial use of cannabis. Cultivation of hemp with up to 0.3% THC will be allowed for the production of non-ingestible products, and cultivation with higher amounts of THC will be allowed for the manufacture of medicines.
21st November 2022
- France: The Senate has approved a resolution on hemp sector economic development and hemp-derived product regulation. Among other things, the Senate is calling on the government to support research on the hemp and CBD sectors, develop uniform and standardised procedures to test CBD concentration, and define a non-binding acceptable daily intake of CBD.
25th October 2022
France: Different political parties have put forward various amendments (181, 755, 1046, 2866, 2879 and 2893) to the 2023 Social Security Financing Bill that would require the government to produce a report analysing the impact of the medical cannabis experiment. Two other amendments (AS688, AS1650), both with the aim of extending the experiment, were adopted last week.
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market data
Up-to-date information and insights on brands, pricing and retail across selected markets
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
